# Metoprolol

Drug · id `cardio:metoprolol` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Lopressor

Browse, organ or system: Heart  
Browse, condition area: High blood pressure; Coronary and vascular disease  

## In plain language

Metoprolol is a beta-adrenergic blocker. The US label read, for Lopressor Oral Solution (metoprolol tartrate, a liquid taken by mouth), says it is indicated in adult patients for hypertension, to lower blood pressure; for the long-term treatment of angina pectoris; and, in hemodynamically stable patients with definite or suspected acute myocardial infarction, to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol.

## Technical summary

RxNorm ingredient 6918; UNII W5S57Y3A5L. The label names the substance as metoprolol tartrate, so UNII W5S57Y3A5L is the UNII of the tartrate salt and is a broad match. MeSH descriptor D008790 is Metoprolol. Class: beta-Adrenergic Blocker (FDA established pharmacologic class, RxClass). The label read is the Validus Pharmaceuticals LLC label for LOPRESSOR Oral Solution (metoprolol tartrate), application NDA219373, effective 2025-05-15 in openFDA. Other metoprolol labels in openFDA, including the LOPRESSOR tablet label and extended-release succinate products, were not read. This page records label indications and the class only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: Adults for whom the US label of metoprolol (Lopressor Oral Solution) lists an indication: hypertension, angina pectoris, definite or suspected acute myocardial infarction

Recipient: Adult; Population: Patients described in the indications section of the label, which says the medicine is indicated in adult patients.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Adults, as the passage read states; Follow-up: Not applicable (label statement)

### The US label of LOPRESSOR Oral Solution (metoprolol tartrate), in the Validus Pharmaceuticals LLC version dated 2025-05-15 in openFDA, lists the medicine, in adult patients, for the treatment of hypertension, to lower blood pressure; for the long-term treatment of angina pectoris; and for hemodynamically stable patients with definite or suspected acute myocardial infarction, to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Adult; Population: Patients described in the indications section of the label, which says the medicine is indicated in adult patients.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Adults, as the passage read states; Follow-up: Not applicable (label statement)
- Limitations: This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-08
- Sources:
  1. Supports: openFDA drug label record for LOPRESSOR Oral Solution (metoprolol tartrate), Validus Pharmaceuticals LLC label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id 9f448171-9588-4a54-88b3-5d870060ce86 (LOPRESSOR Oral Solution; manufacturer Validus Pharmaceuticals LLC, application NDA219373), returned on 2026-11-08. The label text is dated 2025-05-15 (effective\_time). Other openFDA records of metoprolol labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%229f448171-9588-4a54-88b3-5d870060ce86%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\], 1 INDICATIONS AND USAGE. Retrieved 2026-11-08T20:36:50Z. Source state: Current. Version fingerprint: 25523029411d76fb5b7bd58d2ed1c4d5df2146c6fea9ccb8c83dccf569e19758.
     How it applies: The label sentences that give the indications named in the statement, each quoted in the research quote table.
  2. Background: openFDA drug label record for LOPRESSOR Oral Solution (metoprolol tartrate), Validus Pharmaceuticals LLC label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id 9f448171-9588-4a54-88b3-5d870060ce86 (LOPRESSOR Oral Solution; manufacturer Validus Pharmaceuticals LLC, application NDA219373), returned on 2026-11-08. The label text is dated 2025-05-15 (effective\_time). Other openFDA records of metoprolol labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%229f448171-9588-4a54-88b3-5d870060ce86%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-08T20:36:50Z. Source state: Current. Version fingerprint: 25523029411d76fb5b7bd58d2ed1c4d5df2146c6fea9ccb8c83dccf569e19758.
     How it applies: Effective date of the label text read, 20250515.

## Connected pages

- Metoprolol is a beta-adrenergic blocker (FDA established pharmacologic class in RxClass): Beta-blockers (drug class) (`cardio:beta-blockers`)
- FDA label lists hypertension as an indication: Hypertension (high blood pressure) (`core:hypertension`) [a claim, not a settled fact; see claim `cardio:claim-fda-metoprolol-label-indications` and its context]
- FDA label lists reducing cardiovascular mortality in stable patients with definite or suspected acute myocardial infarction as an indication: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`) [a claim, not a settled fact; see claim `cardio:claim-fda-metoprolol-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 9 registry products
- 11 registry trials

## Provenance

Content hash: aa8bbf44c67d4e7ce15a63469149fd7e1b5855e3daadaaec1ddf97a3658c76a5
Last substantive edit: 2026-11-08
Evidence last checked: 2026-11-08
